Le Lézard
Classified in: Health

ASNC's New President, Sharmila Dorbala, MD, MPH, FASNC, Describes Nuclear Cardiology's Vibrant Present - 'On the Leading Edge of Amazing Discoveries'


FAIRFAX, Va., Jan. 23, 2020 /PRNewswire-PRWeb/ -- Please join American Society of Nuclear Cardiology (ASNC) in congratulating Sharmila Dorbala, MD, MPH, FASNC, as she begins her term as the Society's president for 2020. Dr. Dorbala is the director of nuclear cardiology at Brigham and Women's Hospital, Harvard Medical School, in Boston, and is an associate professor of radiology at Harvard. Over more than 20 years as an ASNC member, she has held various officer positions; served on the Board of Directors; and participated on numerous committees, including the education, finance, and audit committees and as vice-chair of the 2017 and 2018 Annual Scientific Sessions Program Committees. She chaired the writing groups for two recent guidelines: the SPECT imaging guidelines released in 2018 and the ASNC/Multisocietal Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis published last year.

In her first President's Message, published in the Journal of Nuclear Cardiology, Dr. Dorbala writes of "Nuclear Cardiology in the Information Age." She describes a field that over just two decades has expanded from a single predominant focus ? myocardial perfusion imaging ? to a multifaceted vista composed of numerous cutting-edge clinical and research frontiers. Innovative technologies have resulted in "a fundamental shift in nuclear cardiology technology," she writes, and have led the field to a horizon where nuclear cardiology and molecular imaging are "on the leading edge of amazing discoveries."

Dr. Dorbala also traces her own journey, from a small town in India to a variety of roles that have enabled her to participate in the growth of nuclear cardiology and ASNC. Auspiciously, she observes, her career has tracked alongside ASNC's growth, starting some 26 years ago when she was applying for residency posts and ASNC's founders were announcing the birth of a new society focused solely on nuclear cardiology. She has witnessed the field's expansion, including some challenging "crossroads," and has been among the many ASNC members who have worked tirelessly to tackle concerns about image quality, radiation exposure and appropriate use. Dr. Dorbala feels honored to been part of propelling the field into the 21st century and, "indeed one of the most exciting times for nuclear cardiology."

She is eager to work with ASNC's members, and the greater nuclear cardiology community, to continue advancing ASNC's priorities, including enhancing digital communications, developing innovative educational products, promoting future leaders, introducing research innovations and contributing to the field's growth. Dr. Dorbala invites others who are interested in furthering this mission to become a member of ASNC and participate in one of several signature events planned for 2020.

ABOUT THE AMERICAN SOCIETY OF NUCLEAR CARDIOLOGY
For over 25 years, the American Society of Nuclear Cardiology and its more than 4,300 members have been improving cardiovascular outcomes through image-guided patient management. As the only society dedicated solely to the field of nuclear cardiology, ASNC establishes standards for excellence in cardiovascular imaging through the development of clinical guidelines, professional medical education, advocacy and research development. ASNC provides peer-reviewed original articles through its - - Journal of Nuclear Cardiology (JNC) and operates the nation's first noninvasive cardiac imaging registry, ImageGuide Registry®, to benchmark quality and improve patient care. For more information, visit http://www.ASNC.org and follow us on @MyASNC and Facebook.

 

SOURCE American Society of Nuclear Cardiology


These press releases may also interest you

at 07:35
Ironwood Pharmaceuticals, Inc. , a GI-focused healthcare company, today announced positive, primary results up to Day 91 for its Phase II exploratory STARGAZE trial evaluating apraglutide in patients with steroid-refractory gastrointestinal acute...

at 07:35
dentalcorp Holdings Ltd. ("dentalcorp" or the "Company") , Canada's largest and one of North America's fastest growing networks of dental practices, today announced that it will present at the following investor conferences: 2024 Bloom Burton & Co....

at 07:30
Optimi Health Corp. (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as natural psilocybin and MDMA, proudly announces its role as a Presenting Sponsor at the highly...

at 07:30
Theratechnologies Inc. ("Theratechnologies" or the "Company") , a biopharmaceutical company focused on the development and commercialization of...

at 07:30
Quipt Home Medical Corp. (the "Company") ?, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the voting results from its annual general and special meeting of shareholders held on March 27, 2024...

at 07:30
Ophthalmic lens technology leader HOYA Vision Care announced the launch of iD LifeStyle® 4 with 3D Binocular Visiontm technology, the newest progressive lens in its award-winning iD LifeStyle® family, now available to order across Canada. Building...



News published on and distributed by: